Mesa Labs announces David Perez and Jenny Alltoft to its Board of Directors

– USA, CO – Mesa Laboratories, Inc. (NASDAQ:MLAB) announces that on January 23, 2019 David B. Perez was appointed to Mesa’s Board, filling the open position created by the passing of H. Stuart Campbell in December 2018, and that today Jennifer S. Alltoft was appointed to Mesa’s Board.

Effective April 4, 2019, Michael T. Brooks will retire from Mesa’s Board, a position he has held for 20 years. Mike has been instrumental in helping guide Mesa’s growth through the years, having served on all of its committees during his tenure. Mike has seen the Company grow revenues from less than $10 million in 1998 to nearly $100 million today. The entire Mesa team is grateful for Mike’s contributions to the Company.

“I would like to welcome David and Jenny to Mesa’s Board and thank Mike for his years of dedication to the Company,” said John Sullivan, Chairman of the Board. “We established a goal for this fiscal year of increasing our Board’s engagement in strategic decision-making by bringing on new members with highly relevant market experience in high growth environments. David and Jenny are perfect fits, bringing many years of involvement and knowledge in our most important healthcare markets of medical devices and pharmaceutical manufacturing. Their insights and guidance in the years ahead will be instrumental in helping Mesa execute its strategic growth plans.”

About David Perez

David is due to retire from his current position as CEO of Terumo BCT on April 1, 2019. In his nearly 20 years at the helm of Terumo BCT, the company grew annual revenues almost six-fold, to nearly $1 billion and he guided the company through multiple changes in name and ownership.

About Jenny Alltoft

Jenny joins after a 32-year career at Pfizer, Inc., where she held multiple positions in Research and Development, Sales & Marketing, Technical Support and General Management. In her most recent experience, she led Pfizer’s Biosimilars business, growing global revenues from zero in 2015 to approximately $800 million today.

About Mesa Laboratories, Inc.

Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Instruments, Cold Chain Monitoring and Cold Chain Packaging) to help our customers ensure product integrity, increase patient and worker safety, and improve quality of life throughout the world.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team

here the original post =>